Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19
Clinical trial NCT04545008 · TERMINATED
Trial details
- NCT number
- NCT04545008
- Sponsor
- Prisma Health-Upstate
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2021-06-02
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.